Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-8.2%
5Y CAGR+7.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-8.2%/yr
vs +69.4%/yr prior
5Y CAGR
+7.0%/yr
Recent deceleration
Acceleration
-77.6pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $20.46M | -10.4% |
| 2024 | $22.83M | -25.4% |
| 2023 | $30.62M | +15.9% |
| 2022 | $26.41M | -7.4% |
| 2021 | $28.53M | +95.1% |
| 2020 | $14.62M | +46.1% |
| 2019 | $10.01M | +212.2% |
| 2018 | $3.21M | - |